Blackrock, INC Schedule 13G passive stakes
NYSE
BlackRock, Inc. has filed an Amendment No. 8 to its Schedule 13G, reporting beneficial ownership of 8.5% of GoPro Inc.'s Class A Common Stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Peakstone Realty Trust, Disclosing 8.6% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 8.6% of Peakstone Realty Trust's common stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an updated Schedule 13G, revealing a passive beneficial ownership of 8.3% in Hilton Worldwide Holdings Inc. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 9.7% Passive Stake in IDEAYA BIOSCIENCES INC
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 9.7% in IDEAYA BIOSCIENCES INC as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.1% Passive Stake in Intrepid Potash, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.1% of Intrepid Potash, Inc.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant Stake in Invesco Mortgage Capital Inc., Disclosing 9.2% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, reaffirming its substantial beneficial ownership of 9.2% in Invesco Mortgage Capital Inc. as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 11.2% of Iridium Communications Inc.'s common stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 18.2% in the iShares MSCI USA Size Factor ETF as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 10.2% in the iShares ESG Advanced MSCI USA ETF as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Kearny Financial Corp to 13.4%
BlackRock, Inc. has filed an amended Schedule 13G, disclosing an increased beneficial ownership of 13.4% in Kearny Financial Corp's common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 9.0% Passive Stake in Keysight Technologies
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.0% passive beneficial ownership stake in Keysight Technologies Inc. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 17.5% Stake in Kite Realty Group Trust
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 17.5% of Kite Realty Group Trust's common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Ligand Pharmaceuticals to 15.6%
BlackRock, Inc. has disclosed an increased beneficial ownership stake of 15.6% in Ligand Pharmaceuticals Inc., holding 2,945,939 shares as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.4% Passive Stake in Borr Drilling Ltd
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.4% passive beneficial ownership stake in Borr Drilling Ltd as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 13.5% beneficial ownership stake in Essent Group Ltd. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant 9.0% Stake in Genpact Ltd.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a continued 9.0% beneficial ownership stake in Genpact Ltd. as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 6.9% of Ultrapar Holdings Inc.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.1% Passive Stake in CGI Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.1% passive beneficial ownership stake in CGI Inc. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.6% Stake in Milestone Pharmaceuticals Inc.
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 7.6% beneficial ownership stake in Milestone Pharmaceuticals Inc. as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 7.3% of Sun Life Financial Inc.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses Nearly 10% Stake in National Grid PLC
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 9.95% of National Grid PLC's common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 12.9% Passive Stake in WPP PLC
BlackRock, Inc. has filed an updated Schedule 13G, revealing a 12.9% beneficial ownership stake in WPP PLC as of December 31, 2024, held for investment purposes.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 9.7% Passive Stake in Nomura Holdings
BlackRock, Inc. has filed an Amendment No. 10 to Schedule 13G, disclosing a 9.7% beneficial ownership stake in Nomura Holdings Inc. as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, disclosing a 4.6% beneficial ownership stake in Globant SA as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.7% Passive Stake in Altimmune, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 8.7% of Altimmune, Inc.'s common stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing its passive beneficial ownership of 11.9% of American Homes 4 Rent's common stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 18.5% of AMERISAFE Inc.'s common stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.3% beneficial ownership stake in Amicus Therapeutics Inc. as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an Amendment No. 8 to its Schedule 13G, disclosing a 14.8% passive beneficial ownership stake in Acadian Asset Management Inc. as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.0% beneficial ownership stake in Cabaletta Bio, Inc. as of December 31, 2024.